A report from the UK indicates that a combination of certain strains of medical cannabis and medicinal mushrooms are effective killing cancerous cells in the breast. Sarah Sinclair, writing for Cannabis Health News, reports that the cannabis-mushroom combination was developed by the Jamaican subsidiary of 
UK-based Apoll on Formularies and the Canadian firm Aion Therapeutic Inc.
Sinclair (pictured here) writes, “Testing showed that Apollon Jamaica’s medical cannabis was “particularly effective” in killing living HER2+ cancer cells directly, while Aion’s medicinal mushroom formulations were most effective in stimulating the immune system’s T-cell production to attack and kill HER2+ cancer cells. “When the two formulations were combined, nearly 100 percent of HER2+ breast cancer cells in 3D cell cultures were killed.”
In 2019, the breast cancer market totaled over US$20 billion, with 68 percent of therapies sold targeting HER2 or CDK4/6.
To read more on this exciting development on the Cannabis Health News website click here